When an interstellar visitor slices through the solar system, astronomers usually have to make do with a fleeting, side-on ...
Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...
VANCOUVER, BC, Dec. 31, 2025 /CNW/ - Goldsky Resources Corp (TSX-V: GSKR, FNSE: GSKR SDB, OTCQX: FNMCD, FRA: HEG0) ("Goldsky ...
Goldsky Resources Corp (FNSE: GSKR SDB) (FRA: HEG0) ("Goldsky Resources " or the "Company") is pleased to announce additional results from its 2025 diamond drill program at the Aida target ("Aida"), ...